Shuttle Pharmaceuticals (SHPH) Competitors $3.30 -0.02 (-0.60%) Closing price 08/29/2025 03:55 PM EasternExtended Trading$3.33 +0.03 (+0.91%) As of 08/29/2025 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SHPH vs. PRPH, NXTC, SNGX, APM, TXMD, MRKR, FLGC, HCWB, ALVR, and BFRGShould you be buying Shuttle Pharmaceuticals stock or one of its competitors? The main competitors of Shuttle Pharmaceuticals include ProPhase Labs (PRPH), NextCure (NXTC), Soligenix (SNGX), Aptorum Group (APM), TherapeuticsMD (TXMD), Marker Therapeutics (MRKR), Flora Growth (FLGC), HCW Biologics (HCWB), AlloVir (ALVR), and Bullfrog AI (BFRG). These companies are all part of the "pharmaceutical products" industry. Shuttle Pharmaceuticals vs. Its Competitors ProPhase Labs NextCure Soligenix Aptorum Group TherapeuticsMD Marker Therapeutics Flora Growth HCW Biologics AlloVir Bullfrog AI ProPhase Labs (NASDAQ:PRPH) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability. Which has more volatility & risk, PRPH or SHPH? ProPhase Labs has a beta of -0.78, meaning that its share price is 178% less volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.08, meaning that its share price is 208% less volatile than the S&P 500. Is PRPH or SHPH more profitable? ProPhase Labs' return on equity of -262.42% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ProPhase LabsN/A -262.42% -76.48% Shuttle Pharmaceuticals N/A -772.76%-347.06% Which has higher valuation and earnings, PRPH or SHPH? Shuttle Pharmaceuticals has lower revenue, but higher earnings than ProPhase Labs. Shuttle Pharmaceuticals is trading at a lower price-to-earnings ratio than ProPhase Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProPhase Labs$6.77M2.07-$53.36M-$1.26-0.27Shuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-0.80 Do institutionals & insiders believe in PRPH or SHPH? 9.5% of ProPhase Labs shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 9.6% of ProPhase Labs shares are held by company insiders. Comparatively, 12.6% of Shuttle Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer PRPH or SHPH? In the previous week, ProPhase Labs and ProPhase Labs both had 1 articles in the media. Shuttle Pharmaceuticals' average media sentiment score of 1.88 beat ProPhase Labs' score of 1.87 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment ProPhase Labs Very Positive Shuttle Pharmaceuticals Very Positive SummaryProPhase Labs beats Shuttle Pharmaceuticals on 7 of the 10 factors compared between the two stocks. Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SHPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SHPH vs. The Competition Export to ExcelMetricShuttle PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.53M$2.49B$5.69B$9.74BDividend YieldN/A48.55%6.64%4.48%P/E Ratio-0.8022.8083.1926.59Price / SalesN/A544.56515.16159.07Price / CashN/A26.3325.6628.92Price / Book0.765.3711.766.08Net Income-$9.15M$32.95M$3.27B$265.93M7 Day Performance-0.60%-0.65%1.13%0.36%1 Month Performance-5.71%6.46%8.30%5.58%1 Year Performance-93.16%-3.15%62.26%19.67% Shuttle Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SHPHShuttle Pharmaceuticals1.4313 of 5 stars$3.30-0.6%N/A-93.2%$3.53MN/A-0.805Upcoming EarningsPRPHProPhase Labs1.3355 of 5 stars$0.34+2.3%N/A-87.4%$14.26M$6.77M-0.27130Positive NewsGap DownNXTCNextCure4.3643 of 5 stars$5.22flat$25.50+388.5%-71.5%$13.97MN/A-0.2090Positive NewsSNGXSoligenix2.2733 of 5 stars$3.14+0.3%$6.00+91.1%-11.4%$13.47M$120K-0.8320Positive NewsAPMAptorum Group1.0954 of 5 stars$2.50+7.3%N/A-34.1%$13.37MN/A0.0030Positive NewsTXMDTherapeuticsMD0.5921 of 5 stars$1.12+1.0%N/A-41.1%$12.97M$1.76M0.00420MRKRMarker Therapeutics3.6206 of 5 stars$1.00-20.6%$13.17+1,216.7%-74.4%$12.94M$6.59M-0.7360Gap UpHigh Trading VolumeFLGCFlora Growth3.2364 of 5 stars$21.88+6.0%$93.00+325.0%-48.3%$12.67M$52.37M-0.64280Positive NewsGap UpHCWBHCW Biologics2.4446 of 5 stars$5.89+6.1%$35.00+494.2%-69.0%$12.66M$2.57M-0.4240ALVRAlloVirN/A$2.51flatN/A-77.2%$12.66MN/A-0.12110News CoverageBFRGBullfrog AI0.7804 of 5 stars$1.25+1.6%N/A-53.1%$12.60M$60K-1.644 Related Companies and Tools Related Companies PRPH Alternatives NXTC Alternatives SNGX Alternatives APM Alternatives TXMD Alternatives MRKR Alternatives FLGC Alternatives HCWB Alternatives ALVR Alternatives BFRG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SHPH) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
